Biotech

All Articles

Basilea credit ratings $268M BARDA backing for antifungals, anti-biotics

.Basilea Pharmaceutica's work creating new antifungals has received a notable improvement coming fro...

Capricor sells Europe liberties to late-stage DMD therapy for $35M

.Possessing presently gathered up the U.S. liberties to Capricor Rehabs' late-stage Duchenne muscula...

FDA scraps adcomm for Applied's unusual health condition drug

.After pushing back the selection meeting for Applied Rehabs' metabolic ailment medicine govorestat,...

Novo inks $600M NanoVation bargain to analyze genetic medications ex-liver

.Novo Nordisk is actually proceeding its push right into genetic medicines, accepting compensate Nan...

Innovent web links cytokine to colon cancer cells responses

.Innovent Biologics has produced the instance that its gate inhibitor-cytokine combination healthy p...

Merck, Daiichi ADC attacks objective in period 3 bronchi cancer research study

.A stage 3 test of Daiichi Sankyo as well as Merck &amp Co.'s HER3-directed antibody-drug conjugate ...

Rakovina strengthens AI center along with collab to pick cancer targets

.5 months after Rakovina Therapeutics pivoted toward expert system, the cancer-focused biotech has a...

Ascendis' dwarfism medicine hits in stage 3, endangers BioMarin

.Ascendis Pharma has actually become a potential danger to BioMarin's Voxzogo, stating period 3 grow...

Despite ph. 3 miss out on, Alkeus views course ahead for eye condition possession

.Though Alkeus Pharmaceuticals' oral eye ailment asset failed to substantially minimize geographical...

Kairos goes social along with $6M IPO to finance tests of cancer cells medicine

.Along with a trio of biotechs striking the Nasdaq on Friday, it was very easy to skip a smaller-sca...